Is This Overlooked EV Maker the Next High-Flying Tesla? Hint: There's Definite Upside.

Polestar reported record 2025 retail sales above 60,000 vehicles, up 34%, with revenue rising 50% to more than $3 billion. However, the net loss widened to nearly $2.4 billion, and while adjusted EBITDA improved by almost $300 million, investors were warned that 2026 volume growth guidance remains in the low double digits. The company is also preparing its largest product offensive yet, but ongoing China exposure and loss-making operations keep the stock in proof-it mode.

Analysis

Polestar’s setup is less a clean EV growth story than a capital-structure and execution trade. The key second-order issue is that its biggest strategic asset—manufacturing and supply-chain proximity to China—also exposes it to the worst part of the global EV cycle: price competition, margin compression, and policy volatility. That means any volume upside from the upcoming product cycle can be offset quickly if the company has to defend share through incentives, especially versus lower-cost Chinese peers and better-capitalized global OEMs.

The market is likely underappreciating how much of the near-term re-rating depends on credibility around gross margin stabilization, not unit growth. A company can show top-line momentum for several quarters while still destroying equity value if working capital, launch costs, and lease/financing support keep cash burn elevated. If management’s guidance implies only low-double-digit growth, the stock remains a financing-dependent asset, and that generally caps multiple expansion until the business proves it can self-fund the next model refresh.

For competitors, the cleaner beneficiaries are premium EV incumbents and suppliers with pricing power rather than “growth at any cost” OEMs. TSLA is the most obvious public comp, but the real read-through is that premium demand remains intact only if launch cadence is matched by margin discipline; otherwise, the market will treat the whole segment as a liquidation scenario. The contrarian view is that investors may be too focused on unit growth and not enough on the probability that the China exposure actually improves product learning curve and cost-down over the next 12–24 months, creating optionality if management can hold the line on spend.

Key Decisions for Investors

• Avoid initiating a long in PSNY here; use any post-launch strength to fade rallies unless the company can demonstrate 2 consecutive quarters of gross margin improvement and reduced cash burn.
• Relative-value long TSLA / short PSNY for 3–6 months: TSLA has scale, pricing leverage, and better access to capital; PSNY remains execution- and financing-sensitive. Best if EV sentiment weakens or China pricing pressure intensifies.
• If you want exposure to the product-cycle upside, buy PSNY only via call spreads after a confirmed launch/ordering catalyst: limited-risk upside with defined premium spend, sized for a 6–9 month horizon.
• Watch for financing or dilution headlines over the next 1–2 quarters; if additional capital raises appear likely, cut any bullish exposure immediately because equity value can reprice faster than operating improvements.
• Prefer suppliers or premium OEM proxies over PSNY in the EV basket until there is evidence that new model launches are translating into sustainable FCF inflection rather than just revenue growth.